We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a cost benefit analysis to evaluate your digital health product.
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
Guidance for manufacturers, importers and distributors on the Product Security and Telecommunications Infrastructure Act 2022 and Regulations 2023.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Check what you need to do to sell cosmetic products in Great Britain.
Use a separate statement of objection form for each Japanese GI product name you object to.
Factsheets accompanying the Product Security and Telecommunications Infrastructure Bill, outlining the problems the Bill will address and how.
Resources for individuals and organisations to use supporting a variety of safety awareness campaigns.
Find product safety alerts, unsafe products and recalls
How to use an interrupted time series to evaluate your digital health product.
Information and resources.
How to use a cost utility analysis to evaluate your digital health product.
How to submit a cosmetic product notification to the Office for Product Safety and Standards (OPSS).
How to use a quasi-experimental study to evaluate your digital health product.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
A list of upcoming webinars on the UK’s approach to product marking and placing products on the market in Great Britain and Northern Ireland.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
Guidance on choosing evaluation study types and methods.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.